1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Chronic Cough Market – By Drug Class
1.3.2 Chronic Cough Market – By Route of Administration
1.3.3 Chronic Cough Market – By Distribution Channel
1.3.4 North America Chronic Cough Market – By Country
2. Chronic Cough Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Chronic Cough Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Expert Opinion
5. Chronic Cough Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic Cough
5.1.2 Growing Product Developments to Treat Chronic Cough
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Aging Population is Expected to Drive Demand for Chronic Cough Treatment
5.4 Future Trends
5.4.1 Continuous Trend of Drug Development
5.5 Impact Analysis
6. Chronic Cough Market Analysis – By Drug Class
6.1 Overview
6.2 Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
6.3 Antihistamines
6.3.1 Overview
6.3.2 Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.4 Corticosteroids
6.4.1 Overview
6.4.2 Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.5 Decongestants
6.5.1 Overview
6.5.2 Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.6 Combination Drug
6.6.1 Overview
6.6.2 Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.7 Antibiotics
6.7.1 Overview
6.7.2 Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.8 Acid Blockers
6.8.1 Overview
6.8.2 Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.9 Other Drug Class
6.9.1 Overview
6.9.2 Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7. Chronic Cough Market – By Route of Administration
7.1 Overview
7.2 Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Injections
7.4.1 Overview
7.4.2 Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Inhalation
7.5.1 Overview
7.5.2 Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Other Route of Administration
7.6.1 Overview
7.6.2 Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8. Chronic Cough Market – By Distribution Channel
8.1 Overview
8.2 Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacy
8.3.1 Overview
8.3.2 Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Online Pharmacy
8.4.1 Overview
8.4.2 Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Retail Pharmacy
8.5.1 Overview
8.5.2 Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
9. Chronic Cough Market – Regional Analysis
9.1 North America Chronic Cough Market
9.1.1 Overview
9.1.2 North America: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 North America: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.5 North America: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
9.1.6 North America: Chronic Cough Market, by Country, 2019 & 2027 (%)
9.1.7 US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 US: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 US: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.7.4 US: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
9.1.8 Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Canada: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 Canada: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.8.4 Canada: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
9.1.9 Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Mexico: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.9.3 Mexico: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.9.4 Mexico: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Chronic cough Market
10.1 Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 MYLAN N.V.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Amneal Pharmaceuticals, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Cipla Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Reckitt Benckiser Group plc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Sun Pharmaceutical Industries Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Aurobindo Pharma Ltd
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary of Terms